Showing results (41-50 of 192) with videos related to

Sort By:
Pageof 20
Current Opinion in Oncology|July 1, 1993
Combined modality treatment of gastrointestinal cancerG Falkson, C I Falkson, C B Falkson
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Cyclophosphamide, doxorubicin and fluorouracil (CAF) plus depo-buserelin in the treatment of premenopausal women with metastatic breast cancerC I Falkson, H C Falkson, G Falkson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancerJ I Raats, G Falkson, H C Falkson
Investigational New Drugs|January 1, 1994
Phase II trial of fotemustine in patients with metastatic malignant melanomaC I Falkson, G Falkson, H C Falkson
American Journal of Clinical Oncology|June 1, 1989
Ifosfamide in advanced carcinoma of the esophagus: a phase II trial with severe toxicityS M Ansell, A S Alberts, G Falkson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanomaC I Falkson, G Falkson, H C Falkson
American Journal of Clinical Oncology|August 1, 1988
High-dose medroxyprogesterone acetate plus mitomycin-C or vindesine in the treatment of advanced breast cancerC I Falkson, H C Falkson, G Falkson
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1992
Fadrozole hydrochloride, a new nontoxic aromatase inhibitor for the treatment of patients with metastatic breast cancerG Falkson, J I Raats, H C Falkson
Pageof 20